15 Biggest Healthcare Companies in USA

Page 4 of 16

13. Gilead Sciences, Inc. (NASDAQ:GILD)

In Gilead Sciences, Inc. (NASDAQ:GILD), 71 funds tracked by Insider Monkey held long positions at the end of the first quarter, compared to 85 funds a quarter earlier. Gilead Sciences, Inc. (NASDAQ:GILD)’s 2016 sales amounted to $30 billion, down from $32.15 billion a year earlier. The decline in Gilead Sciences, Inc. (NASDAQ:GILD)’s sales can be attributed to the 16% drop registered in its Antiviral drug sales, which includes HIV and hepatitis C drugs Harvoni and Sovaldi.

Looker_Studio/Shutterstock.com

Looker_Studio/Shutterstock.com

Follow Gilead Sciences Inc. (NASDAQ:GILD)

Page 4 of 16